This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Device | VENTANA MMR RxDx Panel (Endometrial Cancer with dMMR status) |
Generic Name | Immunohistochemistry Test, Dna Mismatch Repair (mmr) Protein Assay |
Applicant | Ventana Medical Systems1910 E Innovation Park Drivetucson, AZ 85755 PMA NumberP200019 Supplement NumberS004 Date Received02/16/2022 Decision Date07/21/2022 Product Code QNH Advisory Committee Pathology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No |
Date Received | 2022-02-16 |
Decision Date | 2022-07-21 |
PMA | P200019 |
Supplement | S004 |
Product Code | QNH |
Advisory Committee | Pathology |
Supplement Type | Special (immediate Track) |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | Ventana Medical Systems 1910 E Innovation Park Drive tucson, AZ 85755 PMA NumberP200019 Supplement NumberS004 Date Received02/16/2022 Decision Date07/21/2022 Product Code QNH Advisory Committee Pathology Supplement Typespecial (immediate Track) Supplement Reason Labeling Change - Indications/instructions/shelf Life/tradename Expedited Review Granted? No Combination ProductNo Approval Order Statement approval For (i) A Change In Expiry Dating From Hematoxylin And Hematoxylin II And (ii) Implementation Of A Revised Process For Creating Reference Slides Used In Surveillance And Stability Testing Of Hematoxylin And Hematoxylin II |
Supplement Number | Date | Supplement Type |
---|---|---|
P200019 | Original Filing | |
S006 | 2022-10-14 | 30-day Notice |
S005 | 2022-07-12 | 30-day Notice |
S004 | 2022-02-16 | Special (immediate Track) |
S003 | 2022-01-28 | 135 Review Track For 30-day Notice |
S002 | ||
S001 |